Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nova-BioRubber is a biotechnology company specializing in the sustainable production of high-quality natural rubber and hypoallergenic latex. The company utilizes its proprietary, eco-friendly extraction technology to process alternative rubber crops, specifically Taraxacum kok-saghyz (Russian Dandelion) and Guayule. By providing a domestic and sustainable source of rubber, Nova-BioRubber aims to mitigate global supply chain risks associated with Hevea rubber and address the critical need for hypoallergenic materials in the medical device industry. Their innovative approach combines agricultural biotechnology with advanced processing to create high-performance, carbon-sequestering materials suitable for healthcare and industrial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova-BioRubber.